Amplify Weight Loss Drug & Treatment ETF (THNR)

THNR Holdings Information

THNR is an equity ETF with a total of 22 individual holdings. The top holdings are Eli Lilly and Company stock at 12.20%, Novo Nordisk at 9.10%, Chugai Pharmaceutical at 7.89%, Amgen at 7.74%, and Regeneron Pharmaceuticals at 6.67%.

• Total Holdings: 22
• Top 10 Percentage: 72.25%
• Asset Class: Equity
• ETF Category: Health
• Assets: 4.41M
• PE Ratio: 20.73

Top 25 Holdings

As of Feb 26, 2026

Filter results

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	12.20%	519
2	NVO	Novo Nordisk A/S	9.10%	10,513
3	TYO: 4519	Chugai Pharmaceutical Co., Ltd.	7.89%	5,200
4	AMGN	Amgen Inc.	7.74%	887
5	REGN	Regeneron Pharmaceuticals, Inc.	6.67%	376
6	TYO: 4507	Shionogi & Co., Ltd.	6.51%	12,100
7	MRK	Merck & Co., Inc.	5.85%	2,132
8	SWX: ROG	Roche Holding AG	5.70%	527
9	LON: AZN	AstraZeneca PLC	5.48%	1,168
10	PFE	Pfizer Inc.	5.11%	8,199
11	ABBV	AbbVie Inc.	4.86%	940
12	HKG: 1801	Innovent Biologics, Inc.	4.71%	19,000
13	HKG: 1093	CSPC Pharmaceutical Group Limited	4.26%	152,000
14	ARWR	Arrowhead Pharmaceuticals, Inc.	3.75%	2,569
15	VKTX	Viking Therapeutics, Inc.	1.70%	2,236
16	CPH: ZEAL	Zealand Pharma A/S	1.69%	1,295
17	SRRK	Scholar Rock Holding Corporation	1.67%	1,615
18	HIMS	Hims & Hers Health, Inc.	1.50%	4,169
19	AGPXX	Short-Term Investment Trust - Invesco Government & Agency Portfolio	1.31%	57,023
20	KRX: 128940	Hanmi Pharm. Co., Ltd.	1.18%	123
21	JNGHF	Jiangsu Hengrui Pharmaceuticals Co Ltd Ordinary Shares - Class H	0.85%	4,400
22	n/a	OTHER ASSETS AND LIABILITIES	0.27%	173,300,078